370
Views
7
CrossRef citations to date
0
Altmetric
Letters to the Editor

Pembrolizumab-induced Stevens–Johnson Syndrome with Severe Ocular Complications

, MD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD
Pages 1533-1535 | Received 08 Apr 2020, Accepted 22 Feb 2021, Published online: 07 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrew M Philip, Stephen D Anesi, C Stephen Foster & Peter Chang. (2022) Ocular Inflammatory Complications of Treatment for Metastatic Melanoma. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now
Maitry Bhardwaj, Mei Nee Chiu & Sangeeta Pilkhwal Sah. (2022) Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance. Cutaneous and Ocular Toxicology 41:1, pages 73-90.
Read now

Articles from other publishers (5)

Jing-Yi Wu, Kai Kang, Jing Yi & Bin Yang. (2022) Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature. World Journal of Clinical Cases 10:18, pages 6110-6118.
Crossref
Hiroko SUGIMOTO, Akane UEDA, Naoko SHIMOMURA, Kento NODA, Issei SAEKI, Kazuki HAMADA & Yutaka SHIMOMURA. (2022) Two Cases of Cutaneous Adverse Events After Pembrolizumab Administrationペムブロリズマブ投与後に生じた皮膚障害の 2 例. Nishi Nihon Hifuka 84:2, pages 104-109.
Crossref
G. Juan-Carpena, J.C. Palazón-Cabanes & M. Blanes-Martínez. (2022) [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review. Actas Dermo-Sifiliográficas 113:4, pages T376-T387.
Crossref
G. Juan-Carpena, J.C. Palazón-Cabanes & M. Blanes-Martínez. (2022) Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico. Actas Dermo-Sifiliográficas 113:4, pages 376-387.
Crossref
Tetsuya Urasaki, Masatoshi Nishizawa, Atsushi Yoshida, Junichi Tomomatsu, Takeshi Yuasa, Junji Yonese & Shunji Takahashi. (2022) Severe pseudomembranous keratoconjunctivitis with deterioration of eyesight induced by immune checkpoint inhibitors. Immunotherapy 14:3, pages 173-178.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.